Sweden
Cutis Skin Health Sweden AB is a pioneering biotech company founded in 2024, specializing in microbiome-based innovations for skin health. With a foundation in cutting-edge research from the prestigious Karolinska Institutet, Cutis focuses on developing scientifically validated active ingredients and personalized solutions in the realms of dermatology and skincare.
Central to their mission is the integration of molecular insights, enabling the company to seamlessly bridge science and beauty. This approach ensures their products are both microbiome-friendly and effective, delivering healthier skin solutions. Despite its innovative offerings and strong scientific backing, Cutis has not yet attracted external investment, positioning it as a prime opportunity for venture capitalists interested in the intersecting fields of biotechnology and cosmetic dermatology.
The absence of previous investment and the company’s promising research roots make Cutis Skin Health Sweden AB an enticing prospect for investors looking to enter the burgeoning field of microbiome skincare.
